MKC-1106-PP

N/A

Report date: 2026/05/12 09:09:20

Base Information

Drug NameMKC-1106-PP
Drug Alias NameMKC1106-PPMKC-1106-PP
ClassificationVaccines > Development/production technology > Polypeptide vaccineVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOvarian DiseasesUterine Cervical NeoplasmsEndometrial Neoplasms +[21] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMannKind Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMannKind Corp
Active IndicationsN/A
Inactive IndicationsOvarian DiseasesUterine Cervical NeoplasmsEndometrial Neoplasms +[21] 

Other Information

ATC CodeN/A
Related LinksN/A